Publication date: November 2026 Source: Canadian Journal of Diabetes, Volume 50, Issue 7, Supplement Author(s): ZOÉ JARGAILLE, BRUNO MARCOTTE, KERSTIN BELLMANN, RENÉ MALTAIS, JEAN-YVES SANCÉAU, PATRICIA MITCHELL, DONALD POIRIER, OLIVIER BARBIER, ANDRÉ MARETTE
Therapeutic Potential of a Selected Synthetic Analog of Protectin DX for Type 2 Diabetes and Metabolic Liver Disease. // Canadian Journal of Diabetes. – URL: https://www.sciencedirect.com/science/article/pii/S1499267126002790?dgcid=rss_sd_all
Therapeutic Potential of a Selected Synthetic Analog of Protectin DX for Type 2 Diabetes and Metabolic Liver Disease. Canadian Journal of Diabetes. https://www.sciencedirect.com/science/article/pii/S1499267126002790?dgcid=rss_sd_all
“Therapeutic Potential of a Selected Synthetic Analog of Protectin DX for Type 2 Diabetes and Metabolic Liver Disease.” Canadian Journal of Diabetes.
@article{article99835,
title = {Therapeutic Potential of a Selected Synthetic Analog of Protectin DX for Type 2 Diabetes and Metabolic Liver Disease},
journal = {Canadian Journal of Diabetes},
url = {https://www.sciencedirect.com/science/article/pii/S1499267126002790?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...